title: Clinical regression of squamous cell carcinoma and keratoacanthomas in a patient treated with a hypomethylating agent.
authors.affiliation: Department of Hematology and Oncology, Medical College of Wisconsin, Milwaukee, WI, USA E-mail: jrandhaw@mcw.eduDepartment of Dermatology, Medical College of Wisconsin, Milwaukee, WI, USA.
authors.forename: Jasleen
authors.initials: J
authors.lastname: Randhawa
authors.forename: Stuart
authors.initials: S
authors.lastname: Wong
authors.forename: Ehab
authors.initials: E
authors.lastname: Atallah
authors.forename: Edit
authors.initials: E
authors.lastname: Olasz
mesh_terms: D000368:Aged; D000964:Antimetabolites, Antineoplastic / Q000009:adverse effects; D001374:Azacitidine / Q000008:administration & dosage*; D002294:Carcinoma, Squamous Cell / Q000188:drug therapy*; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects; D007636:Keratoacanthoma / Q000188:drug therapy*; D016030:Kidney Transplantation; D008297:Male; D009190:Myelodysplastic Syndromes / Q000188:drug therapy*; D012878:Skin Neoplasms / Q000188:drug therapy*; D016896:Treatment Outcome
chemical_list: D000964:Antimetabolites, Antineoplastic; D007166:Immunosuppressive Agents; D001374:Azacitidine